Congress trades in Coherus Oncology (CHRS)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in Coherus Oncology (CHRS) since 2023: 0 buys and 1 sale. The most recent was disclosed on Feb 9, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $15K–$50K
Who traded CHRS
MemberBuysSalesLast disclosed
- Rep. Shri Thanedar (D-MI-13)0 buys · 1 sale01Feb 9, 2023
All trades
DisclosedTradeAmount
- Feb 9, 2023$15K–$50K
Rep. Shri Thanedar (D-MI-13)
$15K–$50K · Traded Jan 23, 2023 · disclosed Feb 9, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.